何冬林, 韩福国, 王钊, 刘清飞. 基于熔融沉积成型的3D打印在药物制剂中的研究进展J. 药学学报, 2016,51(11): 1659-1665. doi: 10.16438/j.0513-4870.2016-0360
引用本文: 何冬林, 韩福国, 王钊, 刘清飞. 基于熔融沉积成型的3D打印在药物制剂中的研究进展J. 药学学报, 2016,51(11): 1659-1665. doi: 10.16438/j.0513-4870.2016-0360
HE Dong-lin, HAN Fu-guo, WANG Zhao, LIU Qing-fei. A review of 3D printing via fused deposition modeling in pharmaceuticsJ. Acta Pharmaceutica Sinica, 2016,51(11): 1659-1665. doi: 10.16438/j.0513-4870.2016-0360
Citation: HE Dong-lin, HAN Fu-guo, WANG Zhao, LIU Qing-fei. A review of 3D printing via fused deposition modeling in pharmaceuticsJ. Acta Pharmaceutica Sinica, 2016,51(11): 1659-1665. doi: 10.16438/j.0513-4870.2016-0360

基于熔融沉积成型的3D打印在药物制剂中的研究进展

A review of 3D printing via fused deposition modeling in pharmaceutics

  • 摘要: 3D打印是基于数字控制下堆积材料的增量成型方法,而熔融沉积成型是3D打印中常用的技术手段,它通过加热熔化打印材料来构建3D物体。本文回顾近年来基于熔融沉积成型的3D打印在药物制剂方面的研究进展,并总结此项技术的优势之处和限制因素。

     

    Abstract: Three dimensional printing (3D printing) has been known as additive manufacturing technique based on digitally-controlled deposition of materials. Fused deposition modeling (FDM) is one of techniques commonly used in 3D printing, in which materials are soften or melt by heat to create objects during printing. This paper is prepared to review the research and application of 3D printing via FDM in the pharmaceutical sciences, including its advantages and limitations.

     

/

返回文章
返回